UBC researchers identify potential new therapy approach for Hepatitis C that could benefit 170 million people affected worldwide
Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases.
Jan 5, 2012
